Amos Kirilovsky
Overview
Explore the profile of Amos Kirilovsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
14547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El Sissy C, Kirilovsky A, Iseas S, Lagorce Pages C, Zeitoun G, Pages F
J Clin Oncol
. 2024 Feb;
42(9):1088-1089.
PMID: 38306589
No abstract available.
2.
El Sissy C, Kirilovsky A, Lagorce Pages C, Marliot F, Custers P, Dizdarevic E, et al.
J Clin Oncol
. 2023 Oct;
42(1):70-80.
PMID: 37788410
Purpose: No biomarker capable of improving selection and monitoring of patients with rectal cancer managed by watch-and-wait (W&W) strategy is currently available. Prognostic performance of the Immunoscore biopsy (IS) was...
3.
Willis J, Anders R, Torigoe T, Hirohashi Y, Bifulco C, Zlobec I, et al.
Cancers (Basel)
. 2023 Aug;
15(16).
PMID: 37627073
Background: The Immunoscore (IS) is a quantitative digital pathology assay that evaluates the immune response in cancer patients. This study reports on the reproducibility of pathologists' visual assessment of CD3+-...
4.
Mlecnik B, Lugli A, Bindea G, Marliot F, Bifulco C, Lee J, et al.
Cancers (Basel)
. 2023 Jan;
15(2).
PMID: 36672367
Background: The prognostic value of Immunoscore was evaluated in Stage II/III colon cancer (CC) patients, but it remains unclear in Stage I/II, and in early-stage subgroups at risk. An international...
5.
Mlecnik B, Torigoe T, Bindea G, Popivanova B, Xu M, Fujita T, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139506
BACKGROUND: In this study, we evaluated the prognostic value of Immunoscore in patients with stage I−III colon cancer (CC) in the Asian population. These patients were originally included in an...
6.
Kirilovsky A, El Sissy C, Zeitoun G, Marliot F, Haicheur N, Lagorce-Pages C, et al.
Oncotarget
. 2022 Jan;
13:18-31.
PMID: 35018217
Because of the function and anatomical environment of the rectum, therapeutic strategies for local advanced rectal cancer (LARC) must deal with two challenging stressors that are a high-risk of local...
7.
Russick J, Foy P, Josseaume N, Meylan M, Ben Hamouda N, Kirilovsky A, et al.
Front Immunol
. 2021 Jul;
12:701273.
PMID: 34322128
SARS-CoV-2 infection leads to a highly variable clinical evolution, ranging from asymptomatic to severe disease with acute respiratory distress syndrome, requiring intensive care units (ICU) admission. The optimal management of...
8.
Lauret Marie Joseph E, Kirilovsky A, Lecoester B, El Sissy C, Boullerot L, Rangan L, et al.
J Immunother Cancer
. 2021 Jul;
9(7).
PMID: 34230108
Background: Multiple synergistic combination approaches with cancer drugs are developed to overcome primary resistance to immunotherapy; however, the mechanistic rationale to combine chemoradiotherapy (CRT) with immune checkpoint inhibitors remains elusive....
9.
Dragon-Durey M, Chen X, Kirilovsky A, Ben Hamouda N, El Sissy C, Russick J, et al.
PLoS One
. 2021 May;
16(5):e0252026.
PMID: 34038475
To investigate the mechanisms underlying the SARS-CoV-2 infection severity observed in patients with obesity, we performed a prospective study of 51 patients evaluating the impact of multiple immune parameters during...
10.
El Sissy C, Kirilovsky A, Zeitoun G, Marliot F, Haicheur N, Lagorce-Pages C, et al.
Cancers (Basel)
. 2021 Apr;
13(6).
PMID: 33805758
Four decades were needed to progress from the first demonstration of the independent prognostic value of lymphocytes infiltration in rectal cancers to the first recommendation from the international guidelines for...